← Open Payments lookup

CELESTINA ZENAIDA AGUILAR: Open Payments

NPI 1952033235 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,654 in 117 payments from 21 companies in 2025. Trend: 2023 $2,421 · 2024 $1,752 · 2025 $2,654

Food & beverage: $2,654
CompanyPaymentsAmount
ABBVIE INC.54$1,355
PFIZER INC.13$224
Otsuka America Pharmaceutical, Inc.5$201
UCB, Inc.6$146
Novartis Pharmaceuticals Corporation5$128
ARGENX US, INC.6$111
Takeda Pharmaceuticals U.S.A., Inc.3$80
Aucta Pharmaceuticals, Inc.8$78
Teva Pharmaceuticals USA, Inc.2$42
Janssen Biotech, Inc.2$41

Products named: QULIPTA, BOTOX, UBRELVY, NURTEC ODT, REXULTI, Rystiggo, KESIMPTA, VYVGART HYTRULO.

Industry payments across NV — which companies pay providers there.